F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53% Market Closed
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Fluidigm Corp
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fluidigm Corp
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluidigm Corp
F:FLB
Other Current Assets
$9.3m
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
10%
Thermo Fisher Scientific Inc
NYSE:TMO
Other Current Assets
$1.9B
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Other Current Assets
$658m
CAGR 3-Years
-18%
CAGR 5-Years
4%
CAGR 10-Years
1%
Mettler-Toledo International Inc
NYSE:MTD
Other Current Assets
$113.6m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
0%
Agilent Technologies Inc
NYSE:A
Other Current Assets
$334m
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
-17%
IQVIA Holdings Inc
NYSE:IQV
Other Current Assets
$670m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
16%
No Stocks Found

Fluidigm Corp
Glance View

Market Cap
703.6m EUR
Industry
Life Sciences Tools & Services

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
0.67 EUR
Overvaluation 64%
Intrinsic Value
Price
F

See Also

What is Fluidigm Corp's Other Current Assets?
Other Current Assets
9.3m USD

Based on the financial report for Sep 30, 2024, Fluidigm Corp's Other Current Assets amounts to 9.3m USD.

What is Fluidigm Corp's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
10%

Over the last year, the Other Current Assets growth was 174%. The average annual Other Current Assets growth rates for Fluidigm Corp have been 16% over the past three years , 14% over the past five years , and 10% over the past ten years .

Back to Top